Oncology Institute, Inc. (TOI) is a publicly traded company in the Unknown sector. Across all available filings, 25 corporate insiders have executed 232 transactions totaling $41.7M, demonstrating a bearish sentiment with -$41.1M in net insider flow. The most recent transaction on Dec 15, 2025 involved a sale of 13,333 shares valued at $50.3K.
No significant insider buying has been recorded for TOI in the recent period.
No significant insider selling has been recorded for TOI in the recent period.
Based on recent SEC filings, insider sentiment for TOI is bearish with an Insider Alignment Score of 1/100 and a net flow of -$41.1M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Oncology Institute, Inc. (TOI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 25 insiders are actively trading TOI stock, having executed 232 transactions in the past 90 days. The most active insider is Growth I. Gp Llc M33 (Executive), who has made 2 transactions totaling $20.7M.
Get notified when executives and directors at TOI file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | Hively Brad | Executive | Sale | 13,333 | $3.77 | $50.3K | |
| Nov 20, 2025 | Hively Brad | Executive | Award | 41,667 | $N/A | $0 | |
| Nov 20, 2025 | Hively Brad | Executive | Award | 32,407 | $N/A | $0 | |
| Nov 20, 2025 | L. Pacala Mark | Executive | Award | 46,296 | $N/A | $0 | |
| Nov 20, 2025 | L. Pacala Mark | Executive | Award | 35,494 | $N/A | $0 | |
| Nov 20, 2025 | Marie Johnson Karen | Executive | Award | 47,840 | $N/A | $0 | |
| Nov 20, 2025 | Marie Johnson Karen | Executive | Award | 37,037 | $N/A | $0 | |
| Nov 20, 2025 | Ling Gabriel | Executive | Award | 46,296 | $N/A | $0 | |
| Nov 20, 2025 | Ling Gabriel | Executive | Award | 37,037 | $N/A | $0 | |
| Nov 20, 2025 | Kaushal Mohit | Executive | Award | 50,926 | $N/A | $0 | |
| Nov 20, 2025 | Kaushal Mohit | Executive | Award | 40,123 | $N/A | $0 | |
| Nov 20, 2025 | Mcgeorge Anne | Executive | Award | 40,123 | $N/A | $0 | |
| Nov 20, 2025 | Mcgeorge Anne | Executive | Award | 67,901 | $N/A | $0 | |
| Nov 18, 2025 | Ling Gabriel | Executive | Other | 141,149 | $N/A | $0 | |
| Nov 18, 2025 | Llc Toi M, | Executive | Other | 11,818 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 86 | $41.4M | 97.9% |
Exercise(M) | 6 | $362.2K | 0.9% |
Purchase(P) | 17 | $300.9K | 0.7% |
Disposition(D) | 20 | $207.5K | 0.5% |
Award(A) | 90 | $0 | 0.0% |
Other(J) | 11 | $0 | 0.0% |
Conversion(C) | 2 | $0 | 0.0% |
Insider selling pressure at Oncology Institute, Inc. has increased, with 25 insiders executing 232 transactions across all time. Total sales of $41.4M significantly outpace purchases of $300.9K, resulting in a net outflow of $41.1M. This selling activity appears largely discretionary, which may warrant closer attention from investors.